We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Google Buys Hi-Tech Spoon Maker

By HospiMedica International staff writers
Posted on 21 Sep 2014
Image: The Lift Labs tremor-cancelling spoon (Photo courtesy of Lift Labs).
Image: The Lift Labs tremor-cancelling spoon (Photo courtesy of Lift Labs).
Google (Mountain View, CA, USA) has bought Lift Labs (San Francisco, CA, USA), the maker of a tremor-cancelling spoon aimed at improving the lives of people suffering from Parkinson’s disease (PD) and essential tremor.

The company will join Google[x], Google’s research division, which is dedicated to making major technological advancements though ambitious projects known as “moonshots,” such as self-driving cars, delivery drones, and Google glass. The acquisition marks a further move for Google into the biotech and healthcare sectors, following the recent announcement on the development of a special contact lens for diabetics that is capable of monitoring blood-sugar levels.

The Liftware system is designed for people whose hand tremor interferes with daily activities. Sensors in the Liftware base handle detect a person’s tremor, and the device responds using motors to move the spoon opposite the tremor. The device can discern motion from hand tremor from other types of motion, allowing it to respond to just the tremor while preserving the user’s intended motion. In contrast to braces, which force a user’s hand to be still and can cause patient discomfort, Liftware allows the patient’s hand to shake while stabilizing food. Other attachment, such as a key holder, fork, and soup spoon are under development.

“Today we’re welcoming the Lift Labs team into Google[x]. Their tremor-cancelling device could improve quality of life for millions of people,” announced Google on its Google+ page. “We’re also going to explore how their technology could be used in other ways to improve the understanding and management of neurodegenerative diseases such as Parkinson’s disease and essential tremor.”

“We're joining Google[x] and will continue to make and sell our Liftware stabilizers. We could not have reached this point without the support of Rock Health, the National Institutes of Health, our customers, and the hard work of our team,” stated the LiftLab founders. “We're especially excited to work with the Google team to scale our operations and reach even more people who could benefit from using tremor-canceling devices.”

Google co-founder Sergey Brin, whose mother suffers from PD, discovered in 2008 that he also carried a mutation of the LRRK2 gene (G2019S) that increases the risk of developing the disease.

Related Links:

Google
Lift Labs 

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Medical Examination & Procedure Light
Vega 80

Channels

Medical Imaging

view channel
Image: A preclinical rabbit model undergoing longitudinal ocular vascular monitoring before and after induced optic nerve injury (upper panel) and a clinical cohort including patients with cervical lymph nodes of different pathological types (bottom panel) were used to demonstrate the generalizability of the framework. The experimental procedures for both studies include ultrasound data acquisition and reconstruction, extraction and analysis of vascular biomarkers, and construction of diagnostic models. The hierarchical edge-bundling diagram (right) illustrates relationships among ocular biomarkers. Each circular leaf node represents a specific biomarker measured in a particular vascular structure. Node size is proportional to the magnitude of the statistically significant difference observed for that biomarker in this study; larger nodes indicate a greater statistically significant difference. (Photo courtesy of XUEJUN Lab@ShanghaiTech)

Automated Platform Converts Super-Resolution Ultrasound into Vascular Biomarkers

Microvascular dysfunction, an early marker of glaucoma, cancer, and other systemic illnesses, often precedes overt clinical signs yet remains difficult to quantify deep in tissue. Super-resolution ultrasound... Read more